They also cross-reference the worsening of DR status in trials of GLP-1R agonists to early results from the landmark Diabetes Control and Complications Trial, where rapid restoration of euglycaemia was associated with worsening of DR in patients with established retinopathy [221]. This evidence concerns the gene GLP1R and retinal disorder.